Evidence for extended prophylaxis in the setting of orthopedic surgery

Pharmacotherapy

Volumn 24, Issue 7 II, 2004, Pages

  Dobesh, Paul P ^a  

^a ST LOUIS COLLEGE OF PHARMACY   (United States)

Author keywords

Extended prophylaxis; Fondaparinux; Hip fracture surgery; Orthopedic surgery; Venous thromboembolism

Indexed keywords

ANTIVITAMIN K; ARDEPARIN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; FOOD AND DRUG ADMINISTRATION; HIP FRACTURE; HIP SURGERY; HUMAN; KNEE ARTHROPLASTY; LUNG EMBOLISM; META ANALYSIS; ORTHOPEDIC SURGERY; PHLEBOGRAPHY; PRACTICE GUIDELINE; REVIEW; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HUMANS; ORTHOPEDIC PROCEDURES; POLYSACCHARIDES; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 3042720011     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.10.73S.36118     Document Type: Review

References (32)

1. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001;119(suppl 1):S132-75.
2. Frostick S. Death after joint replacement. Hemostasis 2000;30(suppl 2):84-7.
3. Eriksson BI, Bauer KA, Lassen MR, Turpie AGG, for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001;345:1298-304.
4. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525-31.
5. Bergqvist D, Benoni G, Bjorgell O, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996;335:696-700.
6. Planes A, Vochelle N, Darmon JY, et al. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo, Lancet 1996;348: 224-8.
7. Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery: results of a double-blind, prospective, randomized, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997;77: 26-31.
8. Lassen MR, Borris LC, Anderson BS, et al. Efficacy and safety of prolonged thromboprophylaxis with low-molecular-weight heparin (dalteparin) after total hip arthroplasty: the Danish prolonged prophylaxis (DaPP) study. Thromb Res 1998;89: 281-7.
9. Heit JA, Elliott CG, Trowbridge AA, et al. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement: a randomized, double blind, placebo-controlled trial. Ann Intern Med 2000;132:853-61.
10. Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. Arch Intern Med 2000;160:2208-15.
11. Comp PC, Spiro TE, Friedman RJ, et al. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip and/or knee replacement. J Bone Joint Surg Am 2001;83: 336-45.
12. Ricotta S, Iorio A, Parise P, Nenci GG, Agnelli G. Postdischarge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography: an overview analysis. Thromb Haemost 1996;76:887-92.
13. Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. Arch Intern Med 2000;160:2199-207.
14. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001;135:858-69.
15. Eikelboom JW, Quinlian DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001;358:9-15.
16. Haentjens P. Venous thromboembolism after total hip arthroplasty: a review of incidence and prevention during hospitalization and after hospital discharge. Acta Orthop Belg 2000;66:1-8.
17. Manganelli D, Pazzagli M, Mazzantini D, et al. Prolonged prophylaxis with unfractionated heparin is effective to reduce delayed deep vein thrombosis in total hip replacement. Respiration 1998;65:369-74.
18. Monreal M, Lafoz E, Navarro A, et al. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. J Trauma 1989;29:873-5.
19. Barsotti J, Gruel Y, Rosset P, et al. Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur. J Orthop Trauma 1990;4:371-5.
20. Bergqvist D, Kettunen K, Fredin H, et al. Thromboprophylaxis in patients with hip fractures: a prospective, randomized, comparative study between Org 10172 and dextran 70. Surgery 1991;109:617-22.
21. Agnelli G, Cosmi B, Di Filippo P, et al. A randomized, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost 1992;67:203-8.
22. Gent M, Hirsh J, Ginsberg JS, et al. Low-molecular-weight heparinoid Orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Circulation 1996;93:80-4.
23. Borgstrom S, Greitz T, Van Der Linden W, Molin J, Rudics I. Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur: a controlled clinical trial using venous phlebography. Acta Chir Scand 1965;129:500-8.
24. Hamilton HW, Crawford JS, Gardiner JH, Wiley AM. Venous thrombosis in patients with fracture of the upper end of the femur: a phlebographic study of the effect of prophylactic anticoagulation. J Bone Joint Surg Br 1970;52:268-89.
25. Bronge A, Dahlgren S, Lindquist B. Prophylaxis against thrombosis in femoral neck fractures: a comparison between dextran 70 and dicumarol. Acta Chir Scand 1971;137:29-35.
26. Bergquist E, Bergqvist D, Bronge SA, Dahlgren S, Lindquist B. An evaluation of early thrombosis prophylaxis following fracture of the femoral neck: a comparison between dextran and dicoumarol. Acta Chir Scand 1972;138:689-93.
27. Powers PJ, Gent M, Jay RM, et al. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 1989;149:771-4.
28. Eriksson BI, Lassen MR, for the Pentasaccharide in Hip-Fracture Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study Arch Intern Med 2003;163:1337-42.
29. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162: 1833-40.
30. Lassen MR, Bauer KA, Eriksson BI, Turpie AGG, for the European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002;359:1715-20.
31. Turpie AG, Bauer KA, Eriksson BI, Lassen MR, for the PENTATHLON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomiszed double-blind trial. Lancet 2002;359:1721-6. (Erratum in Lancet 2002;360:1102.)
32. Turpie AG, Bauer KA, Eriksson BI, Lassen MR, for the PENTATHLON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomiszed double-blind trial. Lancet 2002;359:1721-6. (Erratum in Lancet 2002;360:1102.)